LABORATORY CORP OF AMERICA HOLDINGS
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
LH$371.83+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
Index
PART I – FINANCIAL INFORMATION
Item 1. Financial Information
CONSOLIDATED BALANCE SHEETS
| December 31,2023 | December 31,2022 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $536.8 | $320.6 |
| Accounts receivable, net | 1,913.3 | 1,785.5 |
| Unbilled services | 185.4 | 211.8 |
| Supplies inventory | 474.6 | 470.6 |
| Prepaid expenses and other | 655.3 | 610.4 |
| Current assets of discontinued operations | — | 1,226.1 |
| Total current assets | 3,765.4 | 4,625.0 |
| Property, plant and equipment, net | 2,911.8 | 2,794.1 |
| Goodwill, net | 6,142.5 | 6,123.7 |
| Intangible assets, net | 3,342.0 | 3,123.6 |
| Joint venture partnerships and equity method investments | 26.9 | 65.7 |
| Deferred income taxes | — | 6.4 |
| Other assets, net | 536.5 | 378.4 |
| Long-term assets of discontinued operations | — | 3,038.2 |
| Total assets | $16,725.1 | $20,155.1 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $827.5 | $852.2 |
| Accrued expenses and other | 804.0 | 787.0 |
| Unearned revenue | 421.7 | 310.6 |
| Short-term operating lease liabilities | 165.8 | 163.8 |
| Short-term finance lease liabilities | 6.4 | 6.0 |
| Short-term borrowings and current portion of long-term debt | 999.8 | 301.3 |
| Current liabilities of discontinued operations | — | 657.6 |
| Total current liabilities | 3,225.2 | 3,078.5 |
| Long-term debt, less current portion | 4,054.7 | 5,038.8 |
| Operating lease liabilities | 648.9 | 652.9 |
| Financing lease liabilities | 78.6 | 83.6 |
| Deferred income taxes and other tax liabilities | 417.9 | 543.4 |
| Other liabilities | 409.3 | 401.1 |
| Long-term liabilities of discontinued operations | — | 241.3 |
| Total liabilities | 8,834.6 | 10,039.6 |
| Commitments and contingent liabilities | ||
| Noncontrolling interest | 15.5 | 18.9 |
| Shareholders’ equity | ||
| Common stock, 83.9 and 88.2 shares outstanding at December 31, 2023 and 2022, respectively | 7.7 | 8.1 |
| Additional paid-in capital | 38.4 | — |
| Retained earnings | 7,888.2 | 10,581.7 |
| Accumulated other comprehensive loss | (59.3) | (493.2) |
| Total shareholders’ equity | 7,875.0 | 10,096.6 |
| Total liabilities and shareholders’ equity | $16,725.1 | $20,155.1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.